Cargando…

Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors

SIMPLE SUMMARY: Microsatellite instability (MSI) is a hallmark of Lynch syndrome (LS)-related tumors but is not specific, as most of MSI/mismatch repair-deficient (dMMR) tumors are sporadic. Therefore, the identification of MSI/dMMR requires additional diagnostic tools to identify LS. In this review...

Descripción completa

Detalles Bibliográficos
Autores principales: Leclerc, Julie, Vermaut, Catherine, Buisine, Marie-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865821/
https://www.ncbi.nlm.nih.gov/pubmed/33530449
http://dx.doi.org/10.3390/cancers13030467
_version_ 1783647936897351680
author Leclerc, Julie
Vermaut, Catherine
Buisine, Marie-Pierre
author_facet Leclerc, Julie
Vermaut, Catherine
Buisine, Marie-Pierre
author_sort Leclerc, Julie
collection PubMed
description SIMPLE SUMMARY: Microsatellite instability (MSI) is a hallmark of Lynch syndrome (LS)-related tumors but is not specific, as most of MSI/mismatch repair-deficient (dMMR) tumors are sporadic. Therefore, the identification of MSI/dMMR requires additional diagnostic tools to identify LS. In this review, we address the hallmarks of LS and present recent advances in diagnostic and screening strategies to identify LS patients. We also discuss the pitfalls associated with current strategies, which should be taken into account in order to improve the diagnosis of LS. ABSTRACT: Microsatellite instability (MSI) is a hallmark of Lynch syndrome (LS)-related tumors but is not specific to it, as approximately 80% of MSI/mismatch repair-deficient (dMMR) tumors are sporadic. Methods leading to the diagnosis of LS have considerably evolved in recent years and so have tumoral tests for LS screening and for the discrimination of LS-related to MSI-sporadic tumors. In this review, we address the hallmarks of LS, including the clinical, histopathological, and molecular features. We present recent advances in diagnostic and screening strategies to identify LS patients. We also discuss the pitfalls associated with the current strategies, which should be taken into account to improve the diagnosis of LS and avoid inappropriate clinical management.
format Online
Article
Text
id pubmed-7865821
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78658212021-02-07 Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors Leclerc, Julie Vermaut, Catherine Buisine, Marie-Pierre Cancers (Basel) Review SIMPLE SUMMARY: Microsatellite instability (MSI) is a hallmark of Lynch syndrome (LS)-related tumors but is not specific, as most of MSI/mismatch repair-deficient (dMMR) tumors are sporadic. Therefore, the identification of MSI/dMMR requires additional diagnostic tools to identify LS. In this review, we address the hallmarks of LS and present recent advances in diagnostic and screening strategies to identify LS patients. We also discuss the pitfalls associated with current strategies, which should be taken into account in order to improve the diagnosis of LS. ABSTRACT: Microsatellite instability (MSI) is a hallmark of Lynch syndrome (LS)-related tumors but is not specific to it, as approximately 80% of MSI/mismatch repair-deficient (dMMR) tumors are sporadic. Methods leading to the diagnosis of LS have considerably evolved in recent years and so have tumoral tests for LS screening and for the discrimination of LS-related to MSI-sporadic tumors. In this review, we address the hallmarks of LS, including the clinical, histopathological, and molecular features. We present recent advances in diagnostic and screening strategies to identify LS patients. We also discuss the pitfalls associated with the current strategies, which should be taken into account to improve the diagnosis of LS and avoid inappropriate clinical management. MDPI 2021-01-26 /pmc/articles/PMC7865821/ /pubmed/33530449 http://dx.doi.org/10.3390/cancers13030467 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Leclerc, Julie
Vermaut, Catherine
Buisine, Marie-Pierre
Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors
title Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors
title_full Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors
title_fullStr Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors
title_full_unstemmed Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors
title_short Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors
title_sort diagnosis of lynch syndrome and strategies to distinguish lynch-related tumors from sporadic msi/dmmr tumors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865821/
https://www.ncbi.nlm.nih.gov/pubmed/33530449
http://dx.doi.org/10.3390/cancers13030467
work_keys_str_mv AT leclercjulie diagnosisoflynchsyndromeandstrategiestodistinguishlynchrelatedtumorsfromsporadicmsidmmrtumors
AT vermautcatherine diagnosisoflynchsyndromeandstrategiestodistinguishlynchrelatedtumorsfromsporadicmsidmmrtumors
AT buisinemariepierre diagnosisoflynchsyndromeandstrategiestodistinguishlynchrelatedtumorsfromsporadicmsidmmrtumors